Home › Funds › Redmile Group, LLC › PRME
Redmile Group, LLC position in PRME
PRIME MEDICINE INC · Health Care
Redmile Group, LLC reported holding 1,389,632 shares of PRME (PRIME MEDICINE INC) in its Q2 2026 13F filing — a position valued at US$5.1M, representing 0.34% of its reported portfolio and ranking #33 among its reported holdings. Redmile Group, LLC has disclosed PRME holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's PRME position evolved
Redmile Group, LLC first disclosed a stake in PRME in Q3 2023 at 1,324,350 shares (US$12.6M). The position peaked in Q1 2024 at 2,074,350 shares, worth US$14.5M. Across 11 filings, Redmile Group, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 1,389,632 shares valued at US$5.1M — a reduction of -201,200 shares quarter over quarter.. Notable position changes include a 57% increase in Q1 2024 (shares fell 27% over the following quarter), a 96% trim in Q3 2025 (shares fell 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.32M | $12.63M | New |
| Q4 2023 | 1.32M | $11.73M | Hold |
| Q1 2024 | 2.07M | $14.52M | Add |
| Q2 2024 | 2.07M | $10.66M | Hold |
| Q3 2024 | 2.07M | $8.03M | Hold |
| Q4 2024 | 2.07M | $6.06M | Hold |
| Q1 2025 | 2.07M | $4.13M | Hold |
| Q2 2025 | 2.07M | $5.12M | Hold |
| Q3 2025 | 87.12K | $482.63K | Reduce |
| Q1 2026 | 1.59M | $5.54M | New |
| Q2 2026 | 1.39M | $5.13M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRME and 13F data
PRME (PRIME MEDICINE INC) is a Health Care company. 36 other funds we track also report a position in PRME — the largest reported positions include Alphabet Inc. (US$61.1M), Casdin Capital (US$11.7M), Alessandra Capital Management, LLC (US$2.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRME
- Alphabet Inc. 16.56M sh · $61.12M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- Alessandra Capital Management, LLC 800.77K sh · $2.45M · Q3 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held PRME?
Redmile Group, LLC has disclosed PRME holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in PRME?
As of Q2 2026, Redmile Group, LLC holds 1.39M shares of PRME (PRIME MEDICINE INC), valued at $5.13M, representing 0.34% of its reported portfolio and ranking #33.
Has Redmile Group, LLC been buying or selling PRME?
In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in PRME. The position peaked in Q1 2024 at 2.07M shares.
Which other funds hold PRME?
Other major institutional holders of PRME include Alphabet Inc., Casdin Capital, Alessandra Capital Management, LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.